Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 38, 2003 - Issue 6
Submit an article Journal homepage
101
Views
114
CrossRef citations to date
0
Altmetric
Research Article

Serum YKL-40, a Potential New Marker of Disease Activity in Patients with Inflammatory Bowel Disease

Vind I. Dept. of Gastroenterology and Rheumatology Hvidovre Hospital University of Copenhagen Denmark
,
Johansen J. S. Dept. of Biology University of California at San Diego La Jolla California USA
,
Price P. A. Dept. of Gastroenterology and Rheumatology Hvidovre Hospital University of Copenhagen Denmark
&
Munkholm P. Dept. of Biology University of California at San Diego La Jolla California USA
Pages 599-605 | Published online: 08 Jul 2009

  • Matthes H, Herbst H, Schuppen D. Cellular localisation of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology 1992; 102:431-42.
  • Lawrence IC, Fiocchi C, Charkravarti S. Differential expression of metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TlMP)-1 and extracellular matrix (ECM) components in fibrosed, inflamed and normal intestine. Gastroenterology 1999;116:A758-9.
  • Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna Classification and clinical activity. Inflamm Bowel Dis 2001(4):306-13.
  • Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
  • Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-55.
  • Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996;271: 19415-20.
  • Shackelton LM, Mann DM, Millis AJT. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 1995; 270: 13076-83.
  • Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1998;251:504-9.
  • Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 2002;365:119-26.
  • De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (Cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 2001;285:926-31.
  • Malinda KM, Ponce L, Kleiman HK, Shack LM, Millis AJT. Gp38k, a protein synthesized by vascular smooth muscle cells stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999;250:168-73.
  • Volck B, Price PA, Johansen JS, Sørensen O, Benfield TL, Nielsen HJ, et al. YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys 1998;110:351-60.
  • Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996;60:540-5.
  • Rehli M, Krause SW, Andresen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 1997;43:221-5.
  • Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997;237: 46-54.
  • Baeten D, Boots AMH, Steenbakkers PGA, Elewaut D, Bos E, Verheijden GFM, et al. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium. Correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000; 43:1233-43.
  • Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001;9:203-14.
  • Boot RG, van Achterberg TAE, van Aken BE, Renkema GH, Jacobs MJHM, Aerts JMFG, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vase Biol 1999;19:687-94.
  • Johansen JS, Baslund B, Garbarsch C, Hansen M, Stoltenberg M, Lorenzen I, et al. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum 1999;42: 2624-30.
  • Johansen JS, Olee T, Price PA, Hashimoto S, Ochs RL, Lotz M. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum 2001;44:826-37.
  • Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992;7:501-12.
  • Morrison BW, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417-26.
  • Harvey S, Weisman M, O'Dell J, Scott T, Krusemeier M, Visor J, et al. Chondrex: new marker of joint disease. Clin Chem 1998; 44:509-16.
  • Johansen JS, Stoltenberg M, Hansen M, Florescu A, HørslevPetersen K, Lorenzen I, et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology 1999;38:618-26.
  • Vos K, Steenbakkers P, Miltenburg AMM, Bos E, van den Heuvel MW, van Hogezand RA, et al. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis 2000:59:544-8.
  • Nordenbaek C, Johansen JS, Junker P, Borregaard N, Sørensen O, Price PA, et al. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with communityacquired pneumonia requiring hospitalization. J Infect Dis 1999; 180:1722-6.
  • Kronborg G, Østergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated to the outcome of the disease. Scand J Infect Dis 2002;34:323-6.
  • Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002;9:598-604.
  • Johansen JS, Cintin C, Jorgensen M, Kamby C, Price PA. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995;31A:1437-42.
  • Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Serum YKL-40 and colorectal cancer. Br J Cancer 1999;79:1494-9.
  • Johansen JS, Christoffersen P, Møller S, Price PA, Henriksen JH, Garbarsch C, et al. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 2000;32:911-20.
  • Tran A, Benzaken S, Saint-Paul M-C, Guzman-Granier E, Hastier P, Pradier C, et al. Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 2000;12:989-93.
  • Vos K, Miltenburg AMM, van Meijgaarden KE, van den Heuvel M, Elferink DJ, van Galen PJM, et al. Cellular immune responses to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions. Rheumatology 2000;39:1326-31.
  • Verheijden GFM, Rijnders AWM, Bos E, Coenen-de Roo CJJ, van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
  • Cope AP, Patel SD, Hall F, Congia M, Hubers HAJM, Verheijden GF, et al. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum 1999; 42: 1497-507.
  • Joosten LAB, Coenen-de Roo CJJ, Helsen MMA, Lubberts E, Boots AMH, van den Berg WB, et al. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/ 1 mice. Arthritis Rheum 2000;43:645-55.
  • Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort study [review thesis]. Dan Med Bull 1997:44:287-302.
  • Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29-32.
  • Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;i:514.
  • Jowett SL, Seal CJ, Barton JR, Welfare MR. Use of the simple colitis activity index (SCCAI). Gut 2001;48 Suppl:A1-A124.
  • Forbes A. Inflammatory bowel disease. A clinicians' guide, 2nd edn. Appendix A, p. 243: Scoring systems in inflammatory bowel disease. London: Arnold; 2001.
  • Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA. Serum Ykl-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 1996;35:553-9.
  • Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increases macrophage subset in inflammatory bowel disease. Apparent recruitment from peripheral blood monocytes. Gut 1994;35:669-74.
  • Kucharzik T, Lgering N, Adolf M, Domschke W, Stoll R. Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci 1997;42:805-12.
  • Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
  • Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.